Published in Pharmacoepidemiol Drug Saf on November 09, 2015
Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan. Schizophr Res (2015) 0.79
Genotype variant associated with add-on memantine in bipolar II disorder. Int J Neuropsychopharmacol (2013) 0.76
Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan. J Affect Disord (2015) 0.75
Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial. Sci Rep (2015) 0.75
A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan. Neuropsychiatr Dis Treat (2015) 0.75
Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C. BMC Psychiatry (2016) 0.75
Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure. Neuropsychiatr Dis Treat (2014) 0.75
Methods of suicide predict the risks and method-switching of subsequent suicide attempts: a community cohort study in Taiwan. Neuropsychiatr Dis Treat (2014) 0.75
Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation. Sci Rep (2017) 0.75
Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder. Sci Rep (2016) 0.75
A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder. Sci Rep (2015) 0.75
miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J Transl Med (2016) 0.75
ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan. J Psychiatr Res (2015) 0.75
Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan. PLoS One (2016) 0.75
The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One (2017) 0.75
Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine. Clin Ther (2016) 0.75
Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan. J Psychiatr Res (2015) 0.75
Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder. Transl Psychiatry (2022) 0.75
Corrigendum to "Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan" [J. Affect. Disord. 189 (2016) 110-117]. J Affect Disord (2015) 0.75
More inflammation but less brain-derived neurotrophic factor in antisocial personality disorder. Psychoneuroendocrinology (2017) 0.75
Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation. Schizophr Res (2017) 0.75